Lycia Therapeutics
Latest round
- Series D
Last raised
- Jun 2026
Total raised
- $277M
Investors
- 17
About Lycia Therapeutics
Established in 2020 by founder Carolyn Bertozzi and based in California, US, Lycia Therapeutics, Inc. specializes in the development of targeted protein degradation therapies to treat diseases by degrading disease-causing proteins. In June 2026, Lycia Therapeutics, Inc. Aetna Wun Trombley is the CEO. Lycia Therapeutics’ primary product focus is on developing LYTAC extracellular protein degraders. These degraders are designed to harness the body’s lysosomal degradation pathways to target and eliminate disease-causing extracellular proteins. The company’s product pipeline includes various LYTAC degraders targeting a range of disease indications, including autoimmune and inflammatory conditions. These therapeutic candidates are designed to degrade soluble and membrane-bound proteins that contribute to disease pathology. Lycia Therapeutics has developed LYTACs across multiple modalities, including low-molecular-weight compounds, antibodies, and bispecific antibodies.
Who invested in Lycia Therapeutics
17 investors across 4 rounds
See all investors in Lycia Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lycia Therapeutics
Who invested in Lycia Therapeutics?
Lycia Therapeutics has 17 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lycia Therapeutics raised?
Lycia Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Lycia Therapeutics last raise money?
Lycia Therapeutics's most recent round on record is a Series D, in Jun 2026.
What does Lycia Therapeutics do?
Established in 2020 by founder Carolyn Bertozzi and based in California, US, Lycia Therapeutics, Inc.
Where is Lycia Therapeutics headquartered?
Lycia Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like Lycia Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Lycia Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Lycia Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.